-
Catlin to make Masters debut after cruising to Hong Kong win
-
Far-right leader Le Pen kicks off tilt at French presidency amid nationwide protests
-
Katsuragawa hails 'greatest moment' with South Korea win
-
Naomi Osaka could quit tennis if daughter asks her to
-
Japan's Yoshida wins first LPGA Tour title with South Korea win
-
Last MotoGP race at Phillip Island cancelled due to weather in Marquez setback
-
Comeback kings Brewers down Rays to take 2-0 World Series lead
-
Sri Lanka seeks faster green energy shift after oil shocks
-
Sri Lankan turbine project fuels anger as fish hauls plunge
-
Riyadh airport resumes flights following Houthi attacks
-
No LeBron, no problem as Sixers roll on
-
'Call of Duty' North Korea invasion edition tops sales charts in South
-
Israel to close all land crossings with West Bank on election day
-
Musk accuses Ukraine of violating Starlink's terms of service
-
'Tech debt coming due': AI-found flaw signals chaos ahead
-
Fed expected to hold rates steady days ahead of US midterms
-
Stop-motion 'Wildwood' showcases 'human creativity' in AI age
-
More Lula, or back to the Bolsonaros? Brazil votes in cliffhanger
-
HKA Enterprises is Powering the Skilled Trades That Are Moving the U.S. Economy Forward
-
Easy Fitness Routines You Can Do at Home
-
7 Creative Things to Do With Your Backyard
-
New Guide Titled "Gold Proof Coins vs Uncirculated Coins: Are Gold Proof Coins a Good Investment" Released
-
Expo Contratista Announces 10th Edition in Dallas, Spotlighting Latino Construction Businesses and Workforce Development
-
Obama blasts Trump's 'chaos and cruelty' while campaigning for Democrats
-
Jorge Martin out of Australian MotoGP with fracture: team
-
Bolsonaro leads Lula in final Brazil election polls
-
Antonelli storms to US Grand Prix pole on weekend he can take title
-
Antonelli storms to pole for US Grand Prix
-
Apologetic Alvarez fires Atletico to win against Deportivo
-
Alvarez fires Atletico to win against Deportivo
-
Lens beat PFC in Ligue 1 matchday impacted by social unrest
-
Japan's Nakai wins Grand Prix de France for second straight year
-
Valkyries hit back against Dream to level WNBA Finals
-
Ronaldinho to make comeback in Italian third tier
-
'Fighting for our rights': Paris protesters determined to march on
-
Israeli forces displace Hebron families after deadly attack
-
Clashes break out in Paris, other French cities amid fresh protests
-
Hamilton on top with Antonelli fourth in final practice at US Grand Prix
-
Spurs seal rare win at Chelsea as Palmer sees red
-
Beier late show sends Dortmund top of Bundesliga
-
Nearly 1,000 arrested in French protests marred by 'elevated' violence: minister
-
Police and protesters clash again at Albanian anti-government rally
-
France extends detention of suspected racist shooter
-
Arteta hails mentality as Arsenal go level with Man City
-
Andrade and Nemour star as Biles cheers at world gymnastics champs
-
Clashes break out in Paris, other cities amid fresh protests
-
Nigeria's Tinubu defends record as economy bites ahead of election
-
Bouthier kicks Vannes to first Top 14 win of season
-
'Guiding star' Fuellkrug bags Bremen brace, Leipzig win
-
Thousands rally for Lula and Bolsonaro on eve of tight Brazil vote
Biorasi Unveils New Website to Drive Sponsor Success with Biotech-Centric Strategies and Modular CRO Solutions
Relaunch puts customized CRO services front and center for today's Biotech and Biopharma innovators.
AVENTURA, FL / ACCESS Newswire / October 8, 2025 / Biorasi, a leading global full-service contract research organization (CRO), has relaunched its website to reflect a bold new direction: Empowering biotech sponsors with modular clinical trial solutions, AI-powered tools, and a renewed focus on sponsor-centric strategy.
"The future of clinical research belongs to those who can adapt, innovate, and deliver," said Chris O'Brien, CEO of Biorasi. "Our new website reflects a strategic evolution - one that puts biotech sponsors at the center of smarter, faster, and more flexible trials. It's a touchstone for the modular solutions and AI-powered tools that will define the next era of clinical success."
Key updates to the website include:
Focused Study Solutions: Critical standalone service offerings deliver the same high-performance features found in Biorasi's full-service strategies:
Study Rescue and Recovery Packages: Designed to salvage struggling clinical trials and restore timelines.
Flexible Data Sciences Solutions: Advanced analytics and biostatistics available as standalone services.
Specialized Services: Including Quality Assurance, Clinical Monitoring, and Safety & Pharmacovigilance, tailored to sponsor needs.
Accelerated Startup Modules: Fast-track solutions for trials requiring rapid market entry.
AI-Powered Feasibility: Dynamic clinical site modeling combined with targeted feasibility outreach and enrollment forecasting.
New Sponsor Strategy: A sharpened focus on the CRO competencies that matter most: Reliability, Flexibility, and Accessibility.
The redesigned website celebrates Biorasi's over two decades of industry leadership, clinical trial experience, and operational excellence:
Over 200 global studies executed.
Five FDA approvals in the past seven years.
$150M+ in recovered rescue studies.
6 weeks or less for database go-live.
Kickoff Meetings in 10 business days after LOI/WO.
60% repeat business from returning sponsors.
Studies conducted in 48 countries, reaching 65% of the global population.
About Biorasi
Biorasi is a global clinical research organization (CRO) that delivers speed-to-market strategies for small to midsized biotech and biopharma sponsors. With over two decades of expertise in running clinical trials across dermatology, oncology, neurology, nephrology, and other key therapeutic areas, Biorasi leverages reliable, flexible, and accessible solutions necessary to succeed in today's dynamic and evolving clinical trials industry. Contact Biorasi at [email protected] / (786) 388-0700.
SOURCE: Biorasi, LLC
View the original press release on ACCESS Newswire
A.O.Scott--AT